Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Research from Dartmouth University yields new findings on immunization
January 28th, 2009
Research findings, 'Variable gene family usage of protective and non-protective anti-Vibrio cholerae O1 LPS antibody heavy chains,' are discussed in a new report. "Vibrio cholerae causes cholera, an enteric disease of humans that is a worldwide problem. The O1 serogroup of Vibrio cholerae contains two predominant serotypes (Inaba and Ogawa) of LPS, a proven protective antigen for humans and experimental animals," researchers in Lebanon report. "We generated B-cell hybridomas from mice immunized with either: (i) two doses of purified Inaba LPS; (ii) two doses of an Inaba hexasaccharide conjugate (terminal six perosamine bound to a protein carrier), (iii)...
Source: Vaccine Weekly (2009-01-28)
|
